Advertisement

GMOs pp 441-462 | Cite as

Governance of Emerging Technologies/Applications in the Bio/Life Sciences: Genome Editing and Synthetic Biology

Chapter
  • 429 Downloads
Part of the Topics in Biodiversity and Conservation book series (TOBC, volume 19)

Abstract

This chapter discusses the issues and challenges in governing genome edited crops and synthetic biology. In case of genome editing, there are global initiatives to assess and identify principles and frameworks for governance. Regarding synthetic biology there is hardly any global initiative on governance despite concerns and Parties to Convention on Biological Diversity are discussing about regulating synthetic biology. Parallelly many ideas and proposals have been put forth on governing these technologies and some of them give emphasis to responsible research and innovation and public engagement, and changes in the regulatory regimes have been advocated. To what extent harmonization of governance at global level is not clear, but for governing these two technologies major revisions in national regulatory regimes would be needed. Given their potential to provide many promising solutions to major problems faced by human kind, harnessing that is possible only when there are effective governance systems that enjoy credibility and are based on science.

Keywords

Genome edited crops Genetically modified organisms Responsible research and innovation Biosafety Product vs. Process CRISPR Cartagena protocol on biosafety Precautionary principle Biological weapons convention Public engagement 

Abbreviations

AHTEG

Ad-Hoc Technical Experts Group

BTWC

Biological and Toxic Weapons Convention

BWC

Biological Weapons Convention

CBD

Convention on Biological Diversity

CPB

Cartagena Protocol on Biosafety

CRISPR

Clustered regularly Interspaced short palindromic repeats

DARPA

Defense Advanced Research Projects Agency (USA)

DIY

Do it yourself

EU

European Union

GEC

Genome edited crops

GMOs

Genetically modified organisms

iGEM

International Genetically Engineered Machine

IRGC

International Risk Governance Council

LMO

Living modified organisms

NIH

National Institutes of Health (USA)

NSF

National Science Foundation

OECD

Organization for Economic Cooperation and Development

RRI

Responsible research and innovation

SPS Agreement

Sanitary and Phytosanitary Agreement (WTO)

TAPIC

Transparency, accountability, participation, integrity, and capacity

WHO

World Health Organization

WTO

World Trade Organization

References

  1. Bartkowski B, Theesfeld I, Pirscher F, Timaeus J (2018) Snipping around for food: economic, ethical and policy implications of CRISPR/Cas genome editing. Geoforum 96:172–180CrossRefGoogle Scholar
  2. Bobek M (2018) Opinion of Advocate General Bobek: Case C-528/16. ECLI:EU:C:2018:20. https://curia.europa.eu/jcms/upload/docs/application/pdf/2018-01/cp180004en.pdf
  3. Bruce A, Bruce D (2019) Genome editing and responsible innovation, can they be reconciled? J Agric Environ Ethics 32:769–788.  https://doi.org/10.1007/s10806-019-09789-wCrossRefGoogle Scholar
  4. Bruetschy C (2019) The EU regulatory framework on genetically modified organisms (GMOs). Transgenic Res 28(Suppl 2):169–174.  https://doi.org/10.1007/s11248-019-00149CrossRefPubMedGoogle Scholar
  5. BWTC (2018) Technical working paper on genome editing and other scientific and technological developments of relevance to the convention BWC/MSP/2018/MX.2/ WP.2 Submitted by Switzerland. https://www.undocs.org/bwc/msp/2018/mx.2/wp.2
  6. Carvalko JM (2020) Conserving humanity at the dawn of posthuman technology Palgrave, New York.  https://doi.org/10.1007/978-3-030-26407-9
  7. Chubb J, Montana J, Stilgoe J, Stirling A, Wilsdon J (2018) A review of recent evidence on the governance of emerging science and technology. Wellcome Trust, London. https://wellcome.ac.uk/sites/default/files/evidence-review-governance-emerging-science-and-technology_0.pdfGoogle Scholar
  8. Collingridge D (1980) The social control of technology. Frances Pinter, London. ISBN 0903804727, 9780903804721Google Scholar
  9. DBT (Department of Biotechnology) (2020) Draft document on genome edited organisms: regulatory framework and guidelines for risk assessment. http://dbtindia.gov.in/sites/default/files/Draft_Regulatory_Framework_Genome_Editing-9jan2020.pdf. New Delhi
  10. Dederer HG, Hamburger D (2019) Introduction: regulation of plants derived from genome editing—what lessons to be learned from other countries? In: Dederer HG, Hamburger D (eds) Regulation of genome editing in plant biotechnology. Cham, Springer, pp 1–17.  https://doi.org/10.1007/978-3-030-17119-3_1CrossRefGoogle Scholar
  11. Doudna J, Sternberg S (2017) Preparing for the global ramifications of gene-editing technology. Global Challenges Foundation. https://globalchallenges.org/our-work/quarterly-reports/globalgovernance-in-the-age-of-disruptivetechnology/preparing-for-the-globalramification
  12. Dürnberger C, Pfeilmeier S, Schleissing S (eds) (2019) Genome editing in agriculture: between precaution and responsibility. Nomos Verlagsgesellschaft, Baden-Baden.  https://doi.org/10.5771/9783845296432-9CrossRefGoogle Scholar
  13. EASAC (European Academies Science Advisory Council) 2020 The regulation of genome-edited plants in the European Union, Brussels https://easac.eu/fileadmin/PDF_s/reports_statements/Genome_Editing/EASAC_Genome-Edited_Plants_Web.pdf
  14. FAO (2019) The status of application, capacities and the enabling environment for agricultural biotechnologies in the Asia-Pacific region. Regional background study. FAO, Bangkok, p 185. Licence: CC BY-NC-SA 3.0 IGO http://www.fao.org/documents/card/en/c/CA4438EN/
  15. Friedrichs S, Takasu Y, Kearns P, Dagallier B, Oshima R, Schofield J, Moreddu C (2019) Meeting report of the OECD conference on “genome editing: applications in agriculture—implications for health, environment and regulation. Transgenic Res 28:419–463.  https://doi.org/10.1007/s11248-019-00154-1CrossRefPubMedPubMedCentralGoogle Scholar
  16. GAIN (Global Agricultural Information Network) of USDA (2020) Agricultural biotechnology annual: European Union report E42019-0053, March 2020, Washington, DCGoogle Scholar
  17. Georgiadis M, Ryznar M (2019) Regulating what has yet to be created: an introduction (July 13, 2019). Texas Law Review Online 98:71–82. Available at SSRN: https://ssrn.com/abstract=3419560
  18. Greely HT (2019) CRISPR’d babies: human germline genome editing in the ‘he Jiankui affair’. J Law Biosci 6(1):111–183.  https://doi.org/10.1093/jlb/lsz010CrossRefPubMedPubMedCentralGoogle Scholar
  19. Hamburger D (2019) Comparative analysis: the regulation of plants derived from genome editing in Argentina, Australia, Canada, the European Union, Japan and the United States. In: Dederer HG, Hamburger D (eds) Regulation of genome editing in plant biotechnology. Springer, Cham.  https://doi.org/10.1007/978-3-030-17119-3_8CrossRefGoogle Scholar
  20. Hundleby PAC, Harwood WA (2019) Impacts of the EU GMO regulatory framework for plant genome editing. Food Energy Secur 8:e00161.  https://doi.org/10.1002/fes3.161CrossRefPubMedGoogle Scholar
  21. IAP (2014) IAP statement on realising global potential in synthetic biology: scientific opportunities and good governance. IAP, TriesteGoogle Scholar
  22. IRGC (2009) Risk governance of synthetic biology. International Risk Governance Council, Geneva, ISBN 978–2–9700672-3-8 IRGC, LausanneGoogle Scholar
  23. Ishii T, Araki M (2017) A future scenario of the global regulatory landscape regarding genome-edited crops. GM Crops Food 8(1):44–56.  https://doi.org/10.1080/21645698.2016.1261787CrossRefPubMedGoogle Scholar
  24. Jiang L (2019) Commercialization of the gene-edited crop and morality: challenges from the liberal patent law and the strict GMO law in the EU. New Genet Soc.  https://doi.org/10.1080/14636778.2019.1686968
  25. Kolodziejczyk B, Kagansky A (2017) Consolidated G20 synthetic biology policies and their role in the 2030 Agenda for Sustainable Development. G20 Insights, G20 Germany 2017 https://globalyoungacademy.net/wp-content/uploads/2017/08/Brief-Consolidated-G20-synthetic-biology-policies-and-their-role-in-the-2030-Agenda-for-Sustainable-Development.pdf
  26. Li H-E, Canavan C, Cameron L et al (2019) Synthetic biology and the United Nations. Trends Biotechnol 37(11):1146–1151.  https://doi.org/10.1016/j.tibtech.2019.05.011CrossRefGoogle Scholar
  27. Mariscal C, Petropanagos A (2016) CRISPR as a driving force: the model T of biotechnology. Monash Bioeth Rev 34(2):101–116.  https://doi.org/10.1007/s40592-016-0062-2CrossRefPubMedGoogle Scholar
  28. Medvedieva MO, Blume YB (2018) Legal regulation of plant genome editing with the CRISPR/Cas9 technology as an example. Cytol Genet 52(3):204–212.  https://doi.org/10.3103/S0095452718030106CrossRefGoogle Scholar
  29. Meyer M, Heimstadr C (2019) The divergent governance of gene editing in agriculture: a comparison of institutional reports from seven EU member states. Plant Biotechnol Rep 13(5):473–482.  https://doi.org/10.1007/s11816-019-00578-5CrossRefGoogle Scholar
  30. National Academies Press (2018) Biodefense in the age of synthetic biology, Washington, DCGoogle Scholar
  31. OIE (2019) Guidelines for responsible conduct in veterinary research. World Organisation for Animal Health.  https://doi.org/10.20506/OIEguidelines.2757
  32. Pirscher F (2019) CRISPR/Cas in crop breeding: why ethics still matter. In: Kallhoff A, Paola D, Schörgenhumer M (eds) Plant ethics, concepts and applications. Routledge, London.  https://doi.org/10.4324/9781315114392CrossRefGoogle Scholar
  33. Rabitz F (2014) Regulatory gaps in the global governance of synthetic biology. In: Issue 2014/11. Institute for European Studies, Brussels. https://www.ies.be/files/PB_2014_11.pdfGoogle Scholar
  34. Raimbault B, Cointet J-P, Joly P-B (2016) Mapping the emergence of synthetic biology. PLoS One 11(9):e0161522.  https://doi.org/10.1371/journal.pone.0161522CrossRefPubMedPubMedCentralGoogle Scholar
  35. Rerimassie V, Stemerding D, Zhang W, Srinivas KR (2015) Discourses on synthetic biology in Europe, India and China. In: Ladikas M, Chaturvedi S, Zhao Y, Stemerding D (eds) Science and technology governance and ethics. Springer, Cham.  https://doi.org/10.1007/978-3-319-14693-5_11CrossRefGoogle Scholar
  36. Ricroch A (2019) Global developments of genome editing in agriculture. Transgenic Res 28:45–52.  https://doi.org/10.1007/s11248-019-00133-6CrossRefPubMedGoogle Scholar
  37. Ricroch AE, Ammann K, Kuntz M (2016) Editing EU legislation to fit plant genome editing. EMBO rep 17:1365–1369.  https://doi.org/10.15252/embr.201643099
  38. Scheben A, Edwards D (2018) Bottlenecks for genome-edited crops on the road from lab to farm. Genome Biol 19:178.  https://doi.org/10.1186/s13059-018-1555-5CrossRefPubMedPubMedCentralGoogle Scholar
  39. Schultz-Bergin M (2018) Is CRISPR an ethical game changer? J Agric Environ Ethics 31(2):219–238.  https://doi.org/10.1007/s10806-018-9721-zCrossRefGoogle Scholar
  40. Shapira P, Kwon S, Youtie J (2017) Tracking the emergence of synthetic biology. Scientometrics 112:1439–1469.  https://doi.org/10.1007/s11192-017-2452-5CrossRefPubMedPubMedCentralGoogle Scholar
  41. Srinivas KR (2019) Global governance of emerging biotechnologies and role of science diplomacy. Sci Dip Rev 1(3):23–30. http://fisd.inGoogle Scholar
  42. Steel D (2014) Philosophy and the precautionary principle: science, evidence, and environmental policy. Cambridge University Press.  https://doi.org/10.1017/CBO9781139939652
  43. Stirling A, Hayes KR, Delborne J (2018) Towards inclusive social appraisal: risk, participation and democracy in governance of synthetic biology. BMC Proc 12(Suppl 8):15.  https://doi.org/10.1186/s12919-018-0111-3CrossRefPubMedPubMedCentralGoogle Scholar
  44. Trump BD (2017) Synthetic biology regulation and governance: lessons from TAPIC for the United States, European Union, and Singapore. Health Policy 121(11):1139–1146.  https://doi.org/10.1016/j.healthpol.2017.07.010CrossRefPubMedGoogle Scholar
  45. Trump BD (2016) A comparative analysis of variations in synthetic biology regulation. Unpublished PhD dissertation, University of Michigan, Ann AborGoogle Scholar
  46. Voigt B, Münichsdorfer A (2019) Regulation of genome editing in plant biotechnology: European Union. In Dederer HG and Hamburger D (ed) regulation of genome editing in plant biotechnology. Springer, Cham, pp 137–238CrossRefGoogle Scholar
  47. Wallach W, Saner M, Marchant G (2018) Beyond cost-benefit analysis in the governance of synthetic biology. Governance of emerging technologies: aligning policy analysis with the Public’s values, special report. Hastings Cent Rep 48(1):S70–S77.  https://doi.org/10.1002/hast.822CrossRefPubMedGoogle Scholar
  48. Walsh B (2019) End times: a brief guide to the end of world. Hachette Books, New YorkGoogle Scholar
  49. Wasmer M (2019) Roads forward for European GMO policy—uncertainties in wake of ECJ judgment have to be mitigated by regulatory reform. Front Bioeng Biotechnol 7(132).  https://doi.org/10.3389/fbioe.2019.00132
  50. Weik A, Guston D, Frow E, Calvert J (2012) Sustainability and anticipatory governance in synthetic biology. Int J Soc Ecol Sust Dev 3(2):25–38.  https://doi.org/10.4018/jsesd.2012040103CrossRefGoogle Scholar
  51. World Bank (2019) Harvesting prosperity: technology and productivity growth in agriculture. World Bank, Washington, DC. https://openknowledge.worldbank.org/handle/10986/32350 License: CC BY 3.0 IGO
  52. Zhang JY, Claire M, Nikolas R (2011) The transnational governance of synthetic biology: scientific uncertainty, cross-borderness and the ‘art’ of governance. For the Royal Society Science Policy Centre (UK) BIOS (Centre for the Study of Bioscience, Biomedicine, Biotechnology and Society), 36 https://kar.kent.ac.uk/36060/
  53. Zhang Y, Pribil M, Palmgren M et al (2020) A CRISPR way for accelerating improvement of food crops. Nat Food.  https://doi.org/10.1038/s43016-020-0051-8

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Research and Information System for Developing Countries (RIS)New DelhiIndia

Personalised recommendations